Drug development or mental health clinics? We explore the benefits of both business strategies for investors in psychedelic stocks.
Drug development or mental health clinics? We explore the benefits of both business strategies for investors in psychedelic stocks.
Red Light Holland imports psilocybin truffles into Canada from its Netherlands supply source.
A Seattle doctor is suing the DEA for blocking access to psilocybin. Could this be the quickest road to psychedelic drug legalization?
Numinus announces a CAD$30 million bought deal financing with units priced at CAD$1.25.
MINDCURE's new COO, Tarik Lebbadi, recently led an international division of Johnson & Johnson.
Part of the benefit from psychedelic medicine may actually be a Placebo Effect. Find out why that is actually a GOOD thing.
Numinus expands its research lab, including more research space, supply capacity and accelerated IP development.
Compass expecting to report data from its Phase IIb study by the end of 2021. Cash on hand decreases to $190.3 million, from $196.5 million the previous quarter.
Adelia Therapeutics, a subsidiary of Cybin Corp., achieves API synthesis and optimization on trypatmine derivatives.
Red Light Holland gets its VR "experience" hosted on the largest PC gaming platform.
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now